update

US FDA issues Dr Reddy's with Form 483 for UK plant

By Gareth Macdonald

- Last updated on GMT

Dr Reddy's API site (source Google maps)
Dr Reddy's API site (source Google maps)

Related tags Dr reddy Food and drug administration

The US Food and Drug Administration (FDA) has found problems at a Dr Reddy’s API plant in the UK.

The Indian drug firm announced the inspection in a Bombay Stock Exchange (BSE) filing​ on Friday, explaining that agency inspectors who visited its facility in Mirfield, Yorkshire issued it with a Form 483 detailing three observations.

Dr Reddy's declined to provide details of the obervations, but did confirm that the plant will continue to supply the US, UK and European markets.

Related topics Ingredients

Related news

Show more

Follow us

Webinars

Headlines